MSA

Mohr Logistics Park Named 2024 "Commercial Development of the Year" CoStar Impact Award Winner

Retrieved on: 
Monday, April 8, 2024

WHITELAND, Ind., April 8, 2024 /PRNewswire/ -- Mohr Logistics Park (MLP) was named the 2024 "Commercial Development of the Year" CoStar Impact Award winner in the Indianapolis market. This year's winners of the CoStar Impact Awards — chosen for their growth, diversification, and ability to overcome unique challenges in their markets — were selected from a panel of more than 660 industry professionals drawn from each respective market.

Key Points: 
  • WHITELAND, Ind., April 8, 2024 /PRNewswire/ -- Mohr Logistics Park (MLP) was named the 2024 "Commercial Development of the Year" CoStar Impact Award winner in the Indianapolis market.
  • The master plan included eleven Class A structures, with varying sizes and specifications to meet growing logistics demands.
  • As Mohr Capital CEO and Indiana native Bob Mohr would say, Mohr Logistics Park is "Hoosier Owned and Hoosier Strong."
  • To learn more about the CoStar Impact Awards and review the full list of winners, visit www.CoStarImpactAwards.com/ .

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Retrieved on: 
Monday, April 8, 2024

Under the MSA, Scinai will provide drug development and cGMP manufacturing services, including aseptic filling and quality assurance, to Ayana, including encapsulating drug substances of various partners of Ayana into Ayana's proprietary liposomal drug delivery system.

Key Points: 
  • Under the MSA, Scinai will provide drug development and cGMP manufacturing services, including aseptic filling and quality assurance, to Ayana, including encapsulating drug substances of various partners of Ayana into Ayana's proprietary liposomal drug delivery system.
  • Ayana COO Yanir Aldouby, commented, "After an extensive search, we are pleased to have selected Scinai Bioservices as our CDMO for our future projects.
  • We were particularly attracted to the team's experience in bio-pharmaceutical drug development and manufacturing for clinical trials while meeting stringent international regulatory requirements.
  • As Scinai is also in the business of biological drug development, we believe they understand our needs as a small biopharma company.

CTO Realty Growth Announces Acquisition of 318,000 Square Foot Retail Power Center in Orlando, Florida for $68.7 Million

Retrieved on: 
Thursday, March 21, 2024

WINTER PARK, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the acquisition of Marketplace at Seminole Towne Center, a 318,000 square foot multi-tenant retail power center in the Sanford submarket of Orlando, Florida (the “Property”) for a purchase price of $68.7 million.

Key Points: 
  • WINTER PARK, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the acquisition of Marketplace at Seminole Towne Center, a 318,000 square foot multi-tenant retail power center in the Sanford submarket of Orlando, Florida (the “Property”) for a purchase price of $68.7 million.
  • The purchase price represents a going-in cap rate within the range of the Company’s current guidance for initial cash yields.
  • Seminole Towne Center is situated on 41 acres along I-4 and SR 417, just over 20 miles north of downtown Olando, Florida.
  • A portion of the acquisition was structured as a reverse like-kind exchange in anticipation of possible future income property dispositions by the Company.

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

Retrieved on: 
Thursday, March 14, 2024

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “We made significant progress in 2023 advancing our three innovative active immunotherapy programs in Phase 2 clinical trials in Alzheimer’s and Parkinson’s diseases.

Key Points: 
  • Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “We made significant progress in 2023 advancing our three innovative active immunotherapy programs in Phase 2 clinical trials in Alzheimer’s and Parkinson’s diseases.
  • Six-month Abeta positron emission tomography (PET) imaging results are expected in Q2 2024, and 12-month Abeta-PET data are expected in H2 2024.
  • Comm., 2023) showed that AC Immune’s wholly-owned a-syn-PET tracer ACI-12589 can detect a-syn pathology in multiple system atrophy (MSA) and differentiate MSA from other a-synucleinopathies.
  • PI-2620 was discovered and developed using the Morphomer® platform as part of a research collaboration between AC Immune and Life Molecular Imaging.

Nokia launches new 25G PON fiber modem to accelerate multi-gigabit broadband deployments

Retrieved on: 
Tuesday, March 12, 2024

New 25G PON fiber modem from Nokia helps operators unlock additional revenue streams through new premium residential, business, and mobile services.

Key Points: 
  • New 25G PON fiber modem from Nokia helps operators unlock additional revenue streams through new premium residential, business, and mobile services.
  • 25G PON allows operators to connect fiber to everything using the same fiber infrastructure to deliver enhanced services and grow revenue.
  • Berlin, Germany – Nokia today announced the launch of a new, symmetrical 25G PON fiber modem.
  • Nokia’s new 25G PON fiber modem allows operators to establish a future-ready network that can immediately address the growing demand for more capacity and enhanced broadband services.

Rio Tinto to manage the Ranger Rehabilitation Project for ERA

Retrieved on: 
Wednesday, April 3, 2024

Rio Tinto will manage the Ranger Rehabilitation Project in Australia’s Northern Territory on behalf of Energy Resources of Australia Ltd (ERA), under a new Management Services Agreement (MSA) signed today.

Key Points: 
  • Rio Tinto will manage the Ranger Rehabilitation Project in Australia’s Northern Territory on behalf of Energy Resources of Australia Ltd (ERA), under a new Management Services Agreement (MSA) signed today.
  • Transition to Rio Tinto management of the project will start immediately and is expected to take about three months.
  • The agreement follows an approach to Rio Tinto from ERA’s Independent Board Committee (IBC) to submit a proposal to provide services and advice to progress the project.
  • Management of ERA matters outside the Ranger Rehabilitation Project, including corporate matters, financial affairs, assets and governance will remain the responsibility of ERA.

West Shore Acquires Preserve at Essex Farms in Charleston, South Carolina, Surpasses 15,000 Units Owned and Operated

Retrieved on: 
Monday, April 1, 2024

West Shore , a fully integrated real estate investment firm with a specific focus on the acquisition and management of multifamily assets, today announced its acquisition of The Preserve at Essex Farms in Charleston, South Carolina.

Key Points: 
  • West Shore , a fully integrated real estate investment firm with a specific focus on the acquisition and management of multifamily assets, today announced its acquisition of The Preserve at Essex Farms in Charleston, South Carolina.
  • This is West Shore’s ninth purchase in the Palmetto State, increasing its total units under ownership and operation in South Carolina to nearly 2,500.
  • The property offers an attractive array of apartment options, from studios to three-bedroom units in a variety of layouts including townhome-style homes.
  • The achievement of owning and operating 15,000 units is a landmark that highlights our successful growth and corporate strategy.”
    The Preserve at Essex Farms is located at 3245 Glenn McConnell Pkwy in Charleston, South Carolina.

TRP Unveils First Two Dispensaries on the Florida West Coast, Celebrating With a Cookies Tampa City Takeover on March 30th

Retrieved on: 
Thursday, March 28, 2024

To celebrate, TRP is hosting a Cookies Tampa City Takeover on Saturday, March 30th.

Key Points: 
  • To celebrate, TRP is hosting a Cookies Tampa City Takeover on Saturday, March 30th.
  • This growth highlights the burgeoning demand for cannabis products and services in the state, providing a compelling backdrop for Cookies Tampa's City Takeover.
  • “The unveiling of both Cookies Tampa locations signifies a pivotal moment for TRP, the Cookies brand, and our mission to elevate access to premium cannabis products,” expressed TRP CEO, Brandon Johnson.
  • This financial success reinforces the strategic significance of Cookies Tampa as it enters Florida’s west coast market.

bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance

Retrieved on: 
Tuesday, March 26, 2024

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported fourth quarter and annual financial results and business highlights for the year ended December 31, 2023, including recent commercial and operational progress.

Key Points: 
  • bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported fourth quarter and annual financial results and business highlights for the year ended December 31, 2023, including recent commercial and operational progress.
  • “In 2023, bluebird established a validated, commercial gene therapy strategy that brought ZYNTEGLO and SKYSONA to individuals living with beta-thalassemia and cerebral adrenoleukodystrophy.
  • Completed 2 patient starts for SKYSONA since the beginning of 2024, in addition to 6 patient starts completed for SKYSONA in 2023.
  • In the first quarter of 2024, bluebird signed its first Medicaid outcomes-based agreement for LYFGENIA with the state of Michigan.

Lumentum Thought Leaders to Present on Leading Edge Innovations and the Role of Photonics in AI Data Centers at OFC 2024

Retrieved on: 
Friday, March 22, 2024

Alan Lowe, CEO and President of Lumentum, will take part in the Optica Executive Forum’s CEO Panel at OFC, discussing the evolution and future of the industry.

Key Points: 
  • Alan Lowe, CEO and President of Lumentum, will take part in the Optica Executive Forum’s CEO Panel at OFC, discussing the evolution and future of the industry.
  • This panel will provide a platform for industry leaders to discuss current challenges, opportunities, and the future of the optical communication industry.
  • This session is scheduled for Wednesday, March 27, 2024, from 5:00 pm to 7:00 pm PDT in Room 15 at OFC.
  • For additional information about Lumentum’s presence at OFC 2024, please visit the official event page at https://www.lumentum.com/en/ofc-2024 or contact the customer service team at [email protected] .